Riskpilot← Back to searchSign inGet full accessGRINIVEIEN 10 AS
ASActiveOrg 988423556Griniveien 10, 0756 OsloRental and operating of own or leased real estate · NACE 6820Est. 20050 employeeswww.cliniquemadeleine.com
Revenue 2024
NOK 350K
0% vs 2023
EBITDA margin
71.8%
0% vs 2023
Equity ratio
11.1%
Financial strength
Net profit 2024
NOK 154K
-7% vs 2023
| Revenue | NOK 350K | +0% |
| EBITDA | NOK 251K | +0% |
| Net profit | NOK 154K | -7% |
| Total assets | NOK 911K | +9% |
| Equity | NOK 101K | +0% |
| Employees | 0 | — |
Legal name
GRINIVEIEN 10 AS
Org number
988423556
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
19. oktober 2005
Share capital
NOK 100 806
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Kjøp, salg og drift av fast eiendom, fabrikasjon, handel og transport, - herunder skipsfart og annen hermed forbunden virksomhet, samt investering, administrering og ledelse av selskaper med virksomhet som nevnt - herunder ervervelse og besittelse av aksjer i slike og andre selskaper.
Address
Griniveien 10, 0756 Oslo
Website
www.cliniquemadeleine.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 252 | 252 | 252 | 350 | 350 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 152 | 165 | 161 | 251 | 251 |
| Depreciation & amort. | −16 | −16 | −16 | −16 | −16 |
| EBIT | 136 | 149 | 145 | 235 | 236 |
| Net financials | −10 | −8 | −10 | −21 | −32 |
| Profit before tax | 126 | 141 | 135 | 214 | 204 |
| Tax | 29 | 33 | 32 | 49 | 50 |
| Net profit | 97 | 107 | 103 | 165 | 154 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 669 | 831 | 793 | 839 | 911 |
| Equity | 101 | 101 | 101 | 101 | 101 |
| Long-term debt | 429 | 562 | 510 | 512 | 581 |
| Short-term debt | 139 | 168 | 182 | 226 | 229 |
| Total debt | 568 | 730 | 692 | 739 | 810 |
EBITDA margin
71.8%
This company
15.8%
Market median
+354% vs market
20202024
Equity ratio
11.1%
This company
38.2%
Market median
-71% vs market
20202024
Return on equity
152.8%
This company
18.4%
Market median
+730% vs market
20202024
Net profit margin
44.0%
This company
8.1%
Market median
+443% vs market
20202024
Asset turnover
0.38×
This company
1.12×
Market median
-66% vs market
20202024
Debt / equity
8.04×
This company
0.62×
Market median
-1197% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
IE Deputy Member | Deputy Member | 2009 |
EL Chief Executive Officer | Chief Executive Officer | 2009 |
IH Deputy Member | Deputy Member | 2009 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Cos Med As
GRINIVEIEN 10 AS Board members of GRINIVEIEN 10 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingelin Engzelius Harlem | Deputy Member | 0 companies |
| Elsebeth Lund Engzelius | Chief Executive Officer | 0 companies |
| Ingelin Harlem | Deputy Member | 0 companies |